Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2025-12-26 @ 10:59 AM
NCT ID:
NCT03510806
Eligibility Criteria:
Inclusion Criteria:
* Ability to consume supplement
* Willing to adhere to the study intervention regimen
* Willing to abstain from analgesics for duration of the study
* Agreement to adhere to Lifestyle Considerations
Exclusion Criteria:
* Current use of NSAIDs
* Use of other nutritional or herbal supplements (e.g., protein powders, tart cherry juice, BCAAs, Vitamin D, probiotics, etc.) that have been shown to effect primary or secondary outcomes
* Presence of chronic diseases, including, but not limited to, cancer, HIV, hepatitis, cardiovascular, metabolic, and orthopedic conditions
* Weight \> 350 pounds
* Pregnancy or lactation
* Known food allergies or sensitivities or dietary restrictions
* Habitual consumption of \> 2 alcoholic drinks per day
* Febrile illness or antibiotic use within 1 month prior to baseline testing
* Treatment with another investigational drug or other intervention within 1 month
* Current smoker or tobacco use within 1 month
* Any condition(s) or diagnosis, both physical or psychological, that, in the opinion of the principal investigator or study physician, precludes participation and/or ability to consent
* Any other factor that, in the opinion of the principal investigator or study physician, would cause harm or increased risk to the participant or close contacts, or preclude the participant's full adherence with or completion of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT03510806
Study Brief:
Protocol Section:
NCT03510806